期刊文献+

Survivin多表位真核表达载体的构建及其在树突状细胞中的表达 被引量:2

Construction of the eukaryotic expression vector encoding multi-epitope fusion protein of human survivin and its expression in dendritic cells
下载PDF
导出
摘要 目的:构建人生存素(survivin)的多表位真核表达载体,并在人树突状细胞(DC)中进行表达。方法:人工合成含4个survivin的HLA-A2类限制性CD8+CTL表位和一个CD4+Th表位的重组cDNA片段,克隆到pBluescript II SK(+)载体上,测序正确后将目的基因连接到真核表达载体pIRESneo3.0中,构建的重组真核表达质粒pPIRESneo3.0-survivin(4)/Th。将其转染人DC并筛选,进行稳定表达。结果:构建了含有survivin的多表位真核表达载体,并成功地转染了人DC。结论:成功地构建了含有survivin的多表位真核表达载体,并在人DC中稳定表达,为进一步研究多表位肿瘤疫苗奠定基础。 AIM: To construct a eukaryotic expression vector encoding the multi-epitope fusion protein of human survivin,and express it in human dendritic cells.METHODS: Recombinant cDNA sequence encoding four HLA-A2-restricted CD8+ CTL epitopes and a CD4+ Th epitope was synthesized and cloned into pBluescript II SK(+) vector.After confirmed by sequencing,the cDNA fragment was inserted to eukaryotic expression vector pIRESneo3.0 to generate the recombinant plasmid pPIRESneo3.0-survivin(4)/Th.The pPIRESneo3.0-survivin(4)/Th was then transfected into human dendritic cells and the transfectants were selected for stable expression.RESULTS: The eukaryotic expression vector encoding the multi-epitope fusion protein of survivin was constructed,and successfully transfected into human dendritic cells.CONCLUSION: The eukaryotic expression vector encoding the multi-epitope fusion protein of survivin has been constructed successfully,and stably expressed in human dendritic cells,which provides clues for further research on multi-epitope cancer vaccine.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第5期498-500,共3页 Chinese Journal of Cellular and Molecular Immunology
关键词 SURVIVIN 多表位 树突状细胞 肿瘤疫苗 survivin multi-epitope dendritic cell cancer vaccine
  • 相关文献

参考文献12

  • 1Andersen MH, Pedersen LO, Becker JC, et al. Identification of a ey- totoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients [ J ]. Cancer Research, 2001, 61 (3) : 869 -872.
  • 2Piesche M, Hildebrandt Y, Zettl F, et al. Identification of a promis- cuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein surviving[ J ]. Human Immunology, 2007, 68 ( 7 ) : 572 - 576.
  • 3孙华文,汤聪,唐启彬,邹声泉,裘法祖.转存活素基因树突状细胞抗消化道肿瘤的免疫效应[J].中华外科杂志,2005,43(5):313-316. 被引量:4
  • 4王健,曹水,任秀宝.脂质体包裹RNA和裸RNA在肿瘤RNA疫苗中作用的比较[J].天津医科大学学报,2008,14(2):215-218. 被引量:3
  • 5Lepisto AJ, Moser AJ, Zeh H, et al. A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors[J]. Cancer Ther, 2008, 6(B) : 955 -964.
  • 6Palmer DH, Midgley RS, Mirza N, et al. A phase Ⅱ study of adop- tive immunotherapy using dendritic cells pulse with lysate in patients with hepatocellnlar carcinoma[ J]. Hepatology, 2009, 49( 1 ) : 124 - 132.
  • 7Avigan DE, Vasir B, George D J, et al. Phase I/II study of vaccina- tion with eleetrofused allogeneic dendritic cells/autologous tumor-de- rived cells in patients with stage IV renal cell carcinoma[J]. J Immu- nother, 2007, 30(7): 749-761.
  • 8Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer thera- py : fulfilled promises and open questions[ J]. Carcinogenesis, 2007, 28(6) : 1133 - 1139.
  • 9Bourgeios C, Rocha B, Tanchot C. A role for CD40 expression on CD8 ^+ T cells in the generation of CD8^+ T cell memory [ J ]. Science, 2002, 297(5589): 2060-2063.
  • 10Janssen EM, Lemmens EE, Wolfe T, et al. CD4^+ T cells are re- quired for secondary expansion and memory in CD8^+ T lymphocytes [J]. Nature, 2003, 421(6925) : 852 -856.

二级参考文献33

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2徐琪 邵莹 张乃宁etal.肿瘤患者自体树突状细胞的建立[J].中国肿瘤生物治疗杂志,1999,6(3):212-212.
  • 3Liu Y, Saxena A, Zheng C, et al. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors. J Gene Med, 2004, 6:857-868.
  • 4Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy.Trends Mol Med,2001, 12: 542-547.
  • 5Terando A, Mule JJ. Enhancing dendritic cell-based vaccines by gene modification.Blood Cells Mol Dis, 2003, 31:80-83.
  • 6Meng H, Lu C, Mabuchi H, et al. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett. 2004, 216:147-155.
  • 7Kawasaki H, Altieri DC, Lu CD. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res, 1998, 22:5071-5074.
  • 8Tu SP, Jiang XH, Lin MC, et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res, 2003 , 22:7724-7732.
  • 9Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res, 1998, 9:1808-1812.
  • 10Ito T, Shiraki K, Sugimoto K. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology, 2000, 5:1080-1085.

共引文献12

同被引文献52

  • 1印春生.合成肽疫苗研究进展[J].中国兽药杂志,2005,39(11):29-33. 被引量:14
  • 2YANG JM, PENG ZH, SI SH, et 01. KAll gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models[J]. Liver International, 2008, 28( 1): 132-139.
  • 3MAC KIEWICZ J, MACKIEWCZ A. Design of clinical trials for therapeutic cancer vaccines development [J]. Eur J Pharmacol, 2009, 625(1-3): 84-89.
  • 4RAY S, CHHABRA A, MEHROTRA S. Obstacles to and opportunities for more effective peptide-bssed therapeutic immunization in human melanoma[J]. Clin Dennatol, 2009, 27 (6): 603-613.
  • 5MEYER D, TORRES JV. Hypervariable epitope construct: a synthetic immunogen that overcomes MHC restriction of antigen presentation[J]. Mol Immunol, 1999, 36( 10): 631-637.
  • 6JIANG L, ZHOU JM, YIN Y, et ol. Selection and identifcation of B-cell epitope on NS 1 protein of dengue virus type 2[J]. Virus Res, 2010, 150( 1 ): 49-55.
  • 7MALHOTRA U, NOUN J, HORTON H, et ol, Functional properties and epitope characteristics of T -cells recognizing natural HIV -1 variants[J]. Vaccine, 2009, 27 ( 48): 6678-6687.
  • 8KAU R M, CHUG H, SNGH H, et 01. Identification and characterization 0 f immunodominant B-cell epitope of the C?terminus of protective antigen of Bacillus anthracis[J]. Mol Immunol, 2009, 46 ( 10): 2107-2115.
  • 9YU X, BARMINA 0, BURGOON M, et aI. Identification of measles virus epitopes using an ultra-fast method of panning phage-displayed random peptide libraries[J]. J Viro Metho, 2009, 156 (1-2): 169-173.
  • 10BRUSIC V, BAJIC VB, PETROVSKY N. Computational methods for prediction of T-cell epitopes-a framework for modeling, testing, and applications[J]. Methods, 2004, 34(4): 436-443.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部